Clinical Trial: Trial of JMKX003142 in Participants with Rapidly Progressive Autosomal Dominant Polycystic Kidney Disease (ADPKD)

U.S., Jan. 31 -- ClinicalTrials.gov registry received information related to the study (NCT06800651) titled 'Trial of JMKX003142 in Participants with Rapidly Progressive Autosomal Dominant Polycystic Kidney Disease (ADPKD)' on Jan. 20.

Brief Summary: A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled Clinical Trial to Evaluate the Efficacy, Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of JMKX003142 in Participants with Rapidly Progressive Autosomal Dominant Polycystic Kidney Disease (ADPKD)

Study Start Date: March 30

Study Type: INTERVENTIONAL

Condition: ADPKD (autosomal Dominant Polycystic Kidney Disease)

Intervention: DRUG: JMKX003142 will be administered orally

JMKX003142 will be administered ora...